IBM Stock Takes a Rare Tumble After Earnings: What to Know
IBM stock is chipping away at its impressive year-to-date return after a Q3 revenue miss, but one analyst isn't worried. Here's why.


International Business Machines (IBM) stock is notably lower in Thursday's session after the technology giant topped third-quarter profit expectations but came up short of revenue estimates.
In the three months ended September 30, IBM's revenue increased 1.5% year over year to $15 billion, driven by a 9.7% jump in sales in its software segment to $6.5 billion. Its earnings per share (EPS) were up 4.6% from the year-ago period to $2.30.
The results were mixed compared with analysts' expectations. Wall Street was anticipating revenue of $15.1 billion and earnings of $2.23 per share, according to CNBC.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"Our third-quarter performance was led by double-digit growth in Software, including a re-acceleration in Red Hat," said IBM CEO Arvind Krishna in a statement. "We continue to see great momentum in artificial intelligence as our models are trusted, fit-for-purpose, and lower cost, with performance leadership. Our generative AI book of business now stands at more than $3 billion, up more than $1 billion quarter to quarter."
For the fourth quarter, IBM said it expects revenue growth consistent with the third quarter. The company also reiterated its full-year forecast for more than $12 billion in free cash flow.
Free cash flow is important to investors because companies "can do a number of useful things with it, such as pay dividends, buy back its stock, acquire other companies, expand its business and knock out its debts," writes Kiplinger contributor Will Ashworth on the importance of good cash flow.
And for IBM, specifically, some of its free cash flow is used to consistently pay and grow its dividend. Indeed, IBM is one of the best dividend stocks for dividend growth, having increased its payout annually for the past 29 years.
Is IBM stock a buy, sell or hold?
Even with Thursday's post-earnings slump, IBM has been one of the best Dow Jones stocks in 2024, up 46% for the year to date on a total return basis (price change plus dividends). But Wall Street doesn't think there's much more room to run.
According to S&P Global Market Intelligence, the average analyst target price for IBM stock is $214.85, which represents a discount to current levels. Additionally, the consensus recommendation is a Hold.
Not everyone is on the sidelines, though. Financial services firm Stifel is one of the more bullish outfits on the blue chip stock, as evidenced by its Buy rating and $246 price target.
"IBM has re-rated higher relative to S&P 500 reflecting improving execution, free cash flow growth and the company's defensive characteristics," says Stifel analyst David Grossman. “We believe the risk/reward remains attractive as the stock could continue to re-rate further with consistent software revenue growth (Red Hat, ELA cycle, and HashiCorp acquisition), the upcoming mainframe cycle and continued free cash flow growth."
Related Content
- Earnings Calendar and Analysis for This Week
- Analysts' Top S&P 500 Stocks to Buy Now
- Is Tesla Stock a Buy After Blowout Earnings?
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Stock Market Today: Have We Seen the Bottom for Stocks?
Solid first-quarter earnings suggest fundamentals remain solid, and recent price action is encouraging too.
By David Dittman
-
Is the GOP Secretly Planning to Raise Taxes on the Rich?
Tax Reform As high-stakes tax reform talks resume on Capitol Hill, questions are swirling about what Republicans and President Trump will do.
By Kelley R. Taylor
-
Stock Market Today: Have We Seen the Bottom for Stocks?
Solid first-quarter earnings suggest fundamentals remain solid, and recent price action is encouraging too.
By David Dittman
-
Social Security Is Taxable, But There Are Workarounds
If you're strategic about your retirement account withdrawals, you can potentially minimize the taxes you'll pay on your Social Security benefits.
By Todd Talbot, CFP®, NSSA, CTS™
-
Serious Medical Diagnosis? Four Financial Steps to Take
A serious medical diagnosis calls for updates of your financial, health care and estate plans as well as open conversations with those who'll fulfill your wishes.
By Thomas C. West, CLU®, ChFC®, AIF®
-
What Wall Street's CEOs Are Saying About Trump's Tariffs
We're in the thick of earnings season and corporate America has plenty to say about the Trump administration's trade policy.
By Karee Venema
-
To Stay on Track for Retirement, Consider Doing This
Writing down your retirement and income plan in an investment policy statement can help you resist letting a bear market upend your retirement.
By Matt Green, Investment Adviser Representative
-
How to Make Changing Interest Rates Work for Your Retirement
Higher (or lower) rates can be painful in some ways and helpful in others. The key is being prepared to take advantage of the situation.
By Phil Cooper
-
When to Sell Your Stock
Knowing when to sell a stock is a major decision investors must make. While there's no one correct answer, we look at some best practices here.
By Charles Lewis Sizemore, CFA
-
Within Five Years of Retirement? Five Things to Do Now
If you're retiring in the next five years, your to-do list should contain some financial planning and, according to current retirees, a few life goals, too.
By Evan T. Beach, CFP®, AWMA®